HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 547 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2023. The put-call ratio across all filers is 3.18 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,167,507 | -45.8% | 79,242 | -51.8% | 0.12% | -44.4% |
| Q2 2023 | $16,922,322 | -5.8% | 164,534 | 0.0% | 0.21% | -15.1% |
| Q1 2023 | $17,957,241 | +174.1% | 164,534 | +100.3% | 0.25% | +137.7% |
| Q2 2022 | $6,552,000 | -21.7% | 82,150 | +3.2% | 0.11% | +2.9% |
| Q1 2022 | $8,373,000 | -23.1% | 79,587 | -21.2% | 0.10% | -7.2% |
| Q4 2021 | $10,886,000 | +65.2% | 101,025 | +68.0% | 0.11% | +42.3% |
| Q3 2021 | $6,589,000 | +1106.8% | 60,150 | +755.0% | 0.08% | +609.1% |
| Q3 2020 | $546,000 | +132.3% | 7,035 | +66.3% | 0.01% | +83.3% |
| Q2 2020 | $235,000 | -73.8% | 4,231 | -86.0% | 0.01% | -80.0% |
| Q1 2020 | $897,000 | -68.1% | 30,300 | -61.0% | 0.03% | -60.0% |
| Q4 2019 | $2,813,000 | +8.9% | 77,700 | -18.1% | 0.08% | -10.7% |
| Q3 2019 | $2,584,000 | – | 94,900 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |